{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:40:49Z","timestamp":1764402049720,"version":"3.44.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ijrobp.2025.05.004","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T10:57:12Z","timestamp":1747220232000},"page":"495-502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Prognostic Impact of MLH1 Promoter Hypermethylation in Stage I-II Endometrial Cancer Treated With Adjuvant Radiation Therapy: A Multi-Institutional Retrospective Study"],"prefix":"10.1016","volume":"123","author":[{"given":"Zohaib K.","family":"Sherwani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shari","family":"Damast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma C.","family":"Fields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil","family":"Beriwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary D.","family":"Horne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric W.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil K.","family":"Taunk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junzo","family":"Chino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea L.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Dyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin V.","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3062-9793","authenticated-orcid":false,"given":"Lara","family":"Hathout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.05.004_bib0001","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.3802\/jgo.2023.34.e85","article-title":"FIGO staging of endometrial cancer: 2023","volume":"34","author":"Berek","year":"2023","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0002","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.prro.2022.09.002","article-title":"Radiation therapy for endometrial cancer: An American society for radiation oncology clinical practice guideline","volume":"13","author":"Harkenrider","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0003","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0004","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/jnci\/djab029","article-title":"Prevalence and prognosis of lynch syndrome and sporadic mismatch repair deficiency in endometrial cancer","volume":"113","author":"Post","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0005","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0006","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.ijrobp.2024.01.203","article-title":"Prognostic effect of mismatch repair status in early-stage endometrial cancer treated with adjuvant radiation: A multi-institutional analysis","volume":"119","author":"Hathout","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0007","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1200\/JCO.23.00062","article-title":"Molecular classification predicts response to radiotherapy in the randomized PORTEC-1 and PORTEC-2 trials for early-stage endometrioid endometrial cancer","volume":"41","author":"Horeweg","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0008","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ygyno.2017.07.003","article-title":"Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival","volume":"146","author":"Cosgrove","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0009","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1158\/1078-0432.CCR-22-0713","article-title":"Microsatellite instability-high endometrial cancers with MLH1 promoter hypermethylation have distinct molecular and clinical profiles","volume":"28","author":"Manning-Geist","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0010","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/s41379-020-0501-8","article-title":"Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma","volume":"33","author":"Pasanen","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0011","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/cam4.3691","article-title":"Mismatch repair protein and MLH1 methylation status as predictors of response to adjuvant therapy in endometrial cancer","volume":"10","author":"Loukovaara","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0012","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.critrevonc.2013.03.002","article-title":"Mismatch repair status and clinical outcome in endometrial cancer: A systematic review and meta-analysis","volume":"88","author":"Diaz-Padilla","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0013","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ygyno.2021.09.018","article-title":"Prognostic impact of mismatch repair deficiency in high- and low-intermediate-risk, early-stage endometrial cancer following vaginal brachytherapy","volume":"163","author":"Li","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0014","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/COC.0000000000000871","article-title":"Effect of mismatch repair status on outcome of early-stage grade 1 to 2 endometrial cancer treated with vaginal brachytherapy","volume":"45","author":"Russo","year":"2022","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0015","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/cncr.31901","article-title":"Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker","volume":"125","author":"Backes","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0016","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ygyno.2009.05.026","article-title":"Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer","volume":"114","author":"Backes","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0017","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.2013.51.2129","article-title":"Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing","volume":"32","author":"Buchanan","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0018","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1200\/JCO.2016.67.8722","article-title":"Clinicopathologic significance of mismatch repair defects in endometrial cancer: An NRG oncologygynecologic oncology group study","volume":"34","author":"McMeekin","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0019","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1200\/JCO.2006.08.2107","article-title":"Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type","volume":"25","author":"Zighelboim","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0020","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ygyno.2021.01.002","article-title":"Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study","volume":"161","author":"Kim","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0022","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/ajcp\/aqab100","article-title":"Endometrial cancer characteristics and risk of recurrence","volume":"157","author":"Borden","year":"2022","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0023","first-page":"109","article-title":"Refining adjuvant treatment in endometrial cancer based on molecular features: The RAINBO clinical trial program","volume":"33","author":"Consortium","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0024","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1136\/ijgc-2020-001929","article-title":"PORTEC-4a: International randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer","volume":"30","author":"van den Heerik","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0025","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1136\/ijgc-2023-004939","article-title":"PErsonalized TReatment for Endometrial Carcinoma (PETREC): Study design and methods of a prospective finnish multicenter trial","volume":"33","author":"Loukovaara","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0026","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/modpathol.2015.43","article-title":"Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative","volume":"28","author":"Stelloo","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0027","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0028","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer\u2013A pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0029","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PGP.0000000000000805","article-title":"Substantial lymphovascular space invasion is an adverse prognostic factor in high-risk endometrial cancer","volume":"41","author":"Peters","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejca.2020.10.011","article-title":"Semiquantitative evaluation of lymph-vascular space invasion in patients affected by endometrial cancer: Prognostic and clinical implications","volume":"142","author":"Restaino","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0031","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ygyno.2024.06.009","article-title":"The prognostic impact of substantial lymphovascular space invasion in women with node negative FIGO stage I uterine carcinoma","volume":"188","author":"Bhatnagar","year":"2024","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0032","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/ijgc-2024-005746","article-title":"Oncologic outcomes based on lymphovascular space invasion in node-negative FIGO 2009 stage I endometrioid endometrial adenocarcinoma: A multicenter retrospective cohort study","volume":"34","author":"Dagher","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0033","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijrobp.2023.02.053","article-title":"Is substantial lymphovascular space invasion prognostic in patients with pathologically lymph node-negative endometrial cancer?","volume":"117","author":"Pifer","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.05.004_bib0034","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/his.15272","article-title":"Practical guidance for assessing and reporting lymphovascular space invasion (LVSI) in endometrial carcinoma","volume":"86","author":"Peters","year":"2025","journal-title":"Histopathology"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162500447X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162500447X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T11:20:35Z","timestamp":1757071235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030162500447X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S036030162500447X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.05.004","relation":{},"ISSN":["0360-3016"],"issn-type":[{"type":"print","value":"0360-3016"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Prognostic Impact of MLH1 Promoter Hypermethylation in Stage I-II Endometrial Cancer Treated With Adjuvant Radiation Therapy: A Multi-Institutional Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}